Sowell Financial Services’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-16,593
Closed -$344K 1043
2025
Q1
$344K Buy
+16,593
New +$417K 0.02% 709
2023
Q3
Sell
-10,585
Closed -$361K 509
2023
Q2
$361K Buy
10,585
+225
+2% +$7.07K 0.02% 493
2023
Q1
$312K Buy
+10,360
New +$321K 0.02% 542
2021
Q2
Sell
-7,001
Closed -$559K 654
2021
Q1
$559K Buy
7,001
+1,617
+30% +$160K 0.02% 604
2020
Q4
$502K Buy
5,384
+1,849
+52% +$147K 0.02% 525
2020
Q3
$225K Buy
3,535
+612
+21% +$35.9K 0.01% 690
2020
Q2
$152K Buy
2,923
+130
+5% +$5.58K 0.01% 819
2020
Q1
$87K Buy
2,793
+253
+10% +$8.45K 0.01% 889
2019
Q4
$85K Hold
2,540
0.01% 965
2019
Q3
$75K Buy
+2,540
New +$82.6K 0.01% 894

Other funds holding ARKG

Sowell Financial Services's ARKG Position: Q2 2025 in Review

Sowell Financial Services sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2025, closing a stake of 16,593 shares — an estimated $344K sold.

Sowell Financial Services first reported a position in ARKG in Q3 2019 and held it in 10 quarters. The position peaked at $559K in Q1 2021. 215 funds tracked by Wall St. Rank hold ARKG as of Q2 2025.

  • Sowell Financial Services reported no remaining ARK Genomic Revolution ETF position as of Q2 2025 after selling out during the quarter.
  • Sowell Financial Services sold 16,593 ARK Genomic Revolution ETF shares in Q2 2025, an estimated $344K.
  • Sowell Financial Services first reported a position in ARK Genomic Revolution ETF in Q3 2019 and held it in 10 quarters.
  • Sowell Financial Services's ARK Genomic Revolution ETF position peaked at $559K in Q1 2021.
  • 215 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2025.

Based on Sowell Financial Services's 13F filing for Q2 2025, filed 14 Jul 2025.